Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary ...

The global preeclampsia drug market is poised for significant growth due to increasing awareness, advancements in diagnostics, and a higher prevalence of hypertension in pregnant women. Preeclampsia, ...

Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the second ...

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th: ProKidney Corp. PROK: This clinical-stage biotechnology company has a Zacks Rank #1 ...

List today: Pharming Group N.V. PHAR: This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days. Pharming Group N.V.

The latest Pharming Group NV American Depositary Shares Repr 10 Shs Reg S stock prices, stock quotes, news, and PHAR history to help you invest and trade smarter.

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

A teenager who lost her mother, aunt and uncle to a genetic condition has become the first person in Europe to receive a ...

Access AS:PHAR financials, view the annual report and financial statements, including income statement, balance sheet, cash flow.

Breakthrough for teen who lost four family members to inherited condition Mary Catchpole, 19, has the same life-threatening genetic condition, activated PI3-Kinase delta syndrome (APDS) ...

A Cambridge teen has become the first person in Europe to receive a “life-changing” drug for a rare genetic condition which contributed to the early deaths of her mother, aunt, uncle and ...

Between 40 to 50 people in England are known to have APDS. The list price for leniolisib is £352,000 per person per year but the company Pharming has agreed a discount for the NHS. The team that ...